Search Results - "MUNDY, G. R"

Refine Results
  1. 1

    MEPE has the properties of an osteoblastic phosphatonin and minhibin by Rowe, P.S.N, Kumagai, Y, Gutierrez, G, Garrett, I.R, Blacher, R, Rosen, D, Cundy, J, Navvab, S, Chen, D, Drezner, M.K, Quarles, L.D, Mundy, G.R

    Published in Bone (New York, N.Y.) (01-02-2004)
    “…Matrix extracellular phosphoglycoprotein (MEPE) is expressed exclusively in osteoblasts, osteocytes and odontoblasts with markedly elevated expression found in…”
    Get full text
    Journal Article
  2. 2

    Transdermal application of lovastatin to rats causes profound increases in bone formation and plasma concentrations by GUTIERREZ, G. E, LALKA, D, GARRETT, I. R, ROSSINI, G, MUNDY, G. R

    Published in Osteoporosis international (01-07-2006)
    “…Statins are drugs that inhibit HMG Co-A reductase and have been shown to enhance bone formation in vitro and in vivo in rodents. However, the statins currently…”
    Get full text
    Journal Article
  3. 3

    The bisphosphonate ibandronate promotes apoptosis in MDA-MB-231 human breast cancer cells in bone metastases by HIRAGA, Toru, WILLIAMS, Paul J, MUNDY, Gregory R, YONEDA, Toshiyuki

    Published in Cancer research (Chicago, Ill.) (01-06-2001)
    “…Bisphosphonate (BP), a specific inhibitor of osteoclasts, has been widely used as a beneficial agent for the treatment of bone metastases in patients with…”
    Get full text
    Journal Article
  4. 4

    Statins and their potential for osteoporosis by Mundy, G.R.

    Published in Bone (01-12-2001)
    “…The observation made several years ago that statins dramatically increase bone formation rates in rodents has provoked a much interest. Statins are natural…”
    Get full text
    Book Review Journal Article
  5. 5
  6. 6

    Requirement of pp60c-src expression for osteoclasts to form ruffled borders and resorb bone in mice by BOYCE, B. F, YONEDA, T, LOWE, C, SORIANO, P, MUNDY, G. R

    Published in The Journal of clinical investigation (01-10-1992)
    “…Targeted disruption of the c-src proto-oncogene in mice has shown that src expression is required for normal bone resorption, since the src-deficient mutants…”
    Get full text
    Journal Article
  7. 7

    Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis by Guise, T A, Yin, J J, Taylor, S D, Kumagai, Y, Dallas, M, Boyce, B F, Yoneda, T, Mundy, G R

    Published in The Journal of clinical investigation (01-10-1996)
    “…Breast cancer almost invariably metastasizes to bone in patients with advanced disease and causes local osteolysis. Much of the morbidity of advanced breast…”
    Get full text
    Journal Article
  8. 8

    Establishment of an Osteocyte‐like Cell Line, MLO‐Y4 by Kato, Yoichi, Windle, Jolene J., Koop, Barbara A., Mundy, Gregory R., Bonewald, Lynda F.

    Published in Journal of bone and mineral research (01-12-1997)
    “…Although osteocytes are the most abundant cells in bone, their functional role remains unclear. In part, this is due to lack of availability of osteocyte cell…”
    Get full text
    Journal Article
  9. 9

    Genetic polymorphisms of EPHX1, Gsk3β, TNFSF8 and myeloma cell DKK-1 expression linked to bone disease in myeloma by Durie, B G M, Van Ness, B, Ramos, C, Stephens, O, Haznadar, M, Hoering, A, Haessler, J, Katz, M S, Mundy, G R, Kyle, R A, Morgan, G J, Crowley, J, Barlogie, B, Shaughnessy, J

    Published in Leukemia (01-10-2009)
    “…Bone disease in myeloma occurs as a result of complex interactions between myeloma cells and the bone marrow microenvironment. A custom-built DNA single…”
    Get full text
    Journal Article
  10. 10

    Statins and bone formation by Garrett, I R, Gutierrez, G, Mundy, G R

    Published in Current pharmaceutical design (01-05-2001)
    “…The main therapy needed most in the bone field is an anabolic agent for the treatment of osteoporosis. Current drugs on the market, which included…”
    Get more information
    Journal Article
  11. 11

    Systemic Administration of Acidic Fibroblast Growth Factor (FGF‐1) Prevents Bone Loss and Increases New Bone Formation in Ovariectomized Rats by Dunstan, C. R., Boyce, R., Boyce, B. F., Garrett, I. R., Izbicka, E., Burgess, W. H., Mundy, G. R.

    Published in Journal of bone and mineral research (01-06-1999)
    “…There are no universally accepted agents that will substantially increase bone mass in osteoporotic patients. A number of peptides important in normal bone…”
    Get full text
    Journal Article Conference Proceeding
  12. 12

    Differential Roles for Bone Morphogenetic Protein (BMP) Receptor Type IB and IA in Differentiation and Specification of Mesenchymal Precursor Cells to Osteoblast and Adipocyte Lineages by Chen, D., Ji, X., Harris, M. A., Feng, J. Q., Karsenty, G., Celeste, A. J., Rosen, V., Mundy, G. R., Harris, S. E.

    Published in The Journal of cell biology (13-07-1998)
    “…Cumulative evidence indicates that osteoblasts and adipocytes share a common mesenchymal precursor and that bone morphogenetic proteins (BMPs) can induce both…”
    Get full text
    Journal Article
  13. 13

    Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo by Hughes, David E., Wright, Kenneth R., Uy, Harry L., Sasaki, Akira, Yoneda, Toshiyuki, Roodman, David G., Mundy, Gregory R., Boyce, Brendan F.

    Published in Journal of bone and mineral research (01-10-1995)
    “…Bisphosphonates inhibit bone resorption and are therapeutically effective in diseases of increased bone turnover, such as Paget's disease and hypercalcemia of…”
    Get full text
    Journal Article
  14. 14

    Hormonal Control of Calcium Homeostasis by Mundy, Gregory R, Guise, Theresa A

    Published in Clinical chemistry (Baltimore, Md.) (01-08-1999)
    “…Calcium homeostasis in the extracellular fluid is tightly controlled and defended physiologically. Hypercalcemia always represents considerable underlying…”
    Get full text
    Journal Article Conference Proceeding
  15. 15

    Osteopetrosis in Src-Deficient Mice is Due to an Autonomous Defect of Osteoclasts by Lowe, Carolyn, Yoneda, Toshiyuki, Boyce, Brendan F., Chen, Hong, Mundy, Gregory R., Soriano, Philippe

    “…Osteopetrosis is a bone modeling disorder resulting in excessive accumulation of bone matrix due to defective function of osteoclasts, the cells that resorb…”
    Get full text
    Journal Article
  16. 16

    Cellular and molecular regulation of bone turnover by Mundy, G.R

    Published in Bone (New York, N.Y.) (01-05-1999)
    Get full text
    Journal Article Conference Proceeding
  17. 17

    Role of transforming growth factor-beta in bone remodeling by Bonewald, L F, Mundy, G R

    Published in Clinical orthopaedics and related research (01-01-1990)
    “…Transforming growth factor-beta (TGF-beta) plays a critical role in bone remodeling. TGF-beta stimulates matrix protein synthesis, has dramatic effects on the…”
    Get more information
    Journal Article
  18. 18

    Metastasis to bone: causes, consequences and therapeutic opportunities by Mundy, Gregory R

    Published in Nature reviews. Cancer (01-08-2002)
    “…The most common human cancers --lung, breast and prostate -- have a great avidity for bone, leading to painful and untreatable consequences. What makes some…”
    Get full text
    Journal Article
  19. 19

    Mechanisms of bone metastasis by Mundy, Gregory R.

    Published in Cancer (15-10-1997)
    “…Solid cancers metastasize to bone by a multistep process that involves interactions between tumor cells and normal host cells. Some tumors, most notably breast…”
    Get full text
    Journal Article Conference Proceeding
  20. 20

    Bisphosphonates as Anticancer Drugs by Mundy, Gregory R, Yoneda, Toshiyuki

    Published in The New England journal of medicine (06-08-1998)
    “…The clinical use of bisphosphonates has increased dramatically during the past five years. The most common indication for these compounds is osteoporosis, but…”
    Get full text
    Journal Article